Skip to content

The safety and cost-effective of Isosurbidemononitrate prior to induction of labor

The safety and cost-effective of Isosurbidemononitrate prior to induction of labor

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201301134850N2
Enrollment
60
Registered
2013-04-16
Start date
2013-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

termination of term pregnancy. Prolonged pregnancy

Interventions

Intervention 1: self adminstration of Isosurbidemononitrate tablet vaginally starting 24,48 h before schedule admission . Intervention 2: self adminstration of placebo tablet vaginally starting 24,4
Treatment - Drugs
Placebo
self adminstration of Isosurbidemononitrate tablet vaginally starting 24,48 h before schedule admission .
self adminstration of placebo tablet vaginally starting 24,48 h before schedule admission .

Sponsors

Vice-chancellor for research of Qazvin University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women have a singleton term pregnancy with a Live fetus; absence of uterine contractions and intact membranes. Exclusion criteria: fetal mal presentations; placenta previa; previous uterine incision or any contraindication of labor induction in ACOG

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Elapsed time induction of labor. Timepoint: Duration based on birth curves records. Method of measurement: Questionnaire.;Elpsed time interval from hospital admission to vaginal delivery. Timepoint: Based on the information entered in the records. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Parity. Timepoint: Age at admission. Method of measurement: Questionnaire.;Age. Timepoint: Age at admission. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shokoh sadat Haji Seyed Abotorabi

Qazvin University Of Medical Sciences & Health Services

shabotorabi@qums.ac.ir+98 28 1223 6374

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026